SMIM10L1
gene geneOn this page
Summary
SMIM10L1 (small integral membrane protein 10 like 1, HGNC:49847) is a protein-coding gene on chromosome 12p13.2, encoding Small integral membrane protein 10-like protein 1 (P0DMW3).
Located in mitochondrion.
Source: NCBI Gene 100129361 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001271592
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:49847 |
| Approved symbol | SMIM10L1 |
| Name | small integral membrane protein 10 like 1 |
| Location | 12p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000256537 |
| Ensembl biotype | protein_coding |
| Entrez | 100129361 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000622602
RefSeq mRNA: 1 — MANE Select: NM_001271592
NM_001271592
CCDS: CCDS81667
Canonical transcript exons
ENST00000622602 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003738263 | 11171194 | 11176016 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 87.86.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 57.0579 / max 341.8678, expressed in 1821 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 124199 | 55.7310 | 1821 |
| 124200 | 1.3269 | 698 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gastrocnemius | UBERON:0001388 | 87.86 | gold quality |
| muscle of leg | UBERON:0001383 | 87.26 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 86.74 | gold quality |
| right adrenal gland | UBERON:0001233 | 86.31 | gold quality |
| left adrenal gland | UBERON:0001234 | 86.03 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 85.93 | gold quality |
| substantia nigra | UBERON:0002038 | 85.91 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 85.17 | gold quality |
| heart left ventricle | UBERON:0002084 | 85.00 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.84 | gold quality |
| Ammon’s horn | UBERON:0001954 | 84.81 | gold quality |
| adrenal gland | UBERON:0002369 | 84.77 | gold quality |
| putamen | UBERON:0001874 | 84.56 | gold quality |
| amygdala | UBERON:0001876 | 84.43 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 84.39 | gold quality |
| temporal lobe | UBERON:0001871 | 84.33 | gold quality |
| hypothalamus | UBERON:0001898 | 84.29 | gold quality |
| heart | UBERON:0000948 | 83.89 | gold quality |
| nucleus accumbens | UBERON:0001882 | 83.74 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 83.64 | gold quality |
| right atrium auricular region | UBERON:0006631 | 83.06 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 83.04 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 83.00 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 82.98 | gold quality |
| cerebral cortex | UBERON:0000956 | 82.92 | gold quality |
| caudate nucleus | UBERON:0001873 | 82.65 | gold quality |
| prefrontal cortex | UBERON:0000451 | 82.64 | gold quality |
| muscle tissue | UBERON:0002385 | 82.45 | gold quality |
| frontal cortex | UBERON:0001870 | 82.37 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 82.26 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-112 | yes | 6.49 |
| E-ANND-3 | no | 1.01 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
133 targeting SMIM10L1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
Literature-anchored findings (GeneRIF, showing 1)
- Small integral membrane protein 10 like 1 downregulation enhances differentiation of adipose progenitor cells. (PMID:35290761)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | smim10l3 | ENSDARG00000100331 |
| mus_musculus | Smim10l1 | ENSMUSG00000072704 |
| rattus_norvegicus | Smim10l1 | ENSRNOG00000047309 |
Paralogs (4): SMIM10L2A (ENSG00000178947), SMIM10 (ENSG00000184785), SMIM10L2B (ENSG00000196972), SMIM10L3 (ENSG00000286075)
Protein
Protein identifiers
Small integral membrane protein 10-like protein 1 — P0DMW3 (reviewed: P0DMW3)
All UniProt accessions (1): P0DMW3
RefSeq proteins (1): NP_001258521* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029367 | SMIM10 | Family |
Pfam: PF15118
UniProt features (2 total): chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DMW3-F1 | 69.27 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 69 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, DACOSTA_UV_RESPONSE_VIA_ERCC3_UP, CADWELL_ATG16L1_TARGETS_DN, DODD_NASOPHARYNGEAL_CARCINOMA_UP, TIEN_INTESTINE_PROBIOTICS_24HR_UP, MULLIGHAN_MLL_SIGNATURE_1_UP, TIEN_INTESTINE_PROBIOTICS_6HR_DN, SNF5_DN.V1_DN, ATF5_TARGET_GENES, NKX2_2_TARGET_GENES, SETD7_TARGET_GENES, ZNF22_TARGET_GENES, ZNF30_TARGET_GENES, ZNF33A_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
36 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SMIM10L1 | TNS2 | Q63HR2 | 433 |
| SMIM10L1 | TNS4 | Q8IZW8 | 432 |
| SMIM10L1 | TNS3 | Q68CZ2 | 399 |
| SMIM10L1 | TNS1 | Q9HBL0 | 396 |
| SMIM10L1 | SREBF1 | P36956 | 192 |
| SMIM10L1 | TRIT1 | Q9H3H1 | 166 |
| SMIM10L1 | DNPEP | Q9ULA0 | 161 |
| SMIM10L1 | IWS1 | Q96ST2 | 158 |
| SMIM10L1 | TMEM254 | Q8TBM7 | 154 |
| SMIM10L1 | WDR31 | Q8NA23 | 143 |
| SMIM10L1 | RACK1 | P25388 | 143 |
| SMIM10L1 | PTEN | P60484 | 120 |
| SMIM10L1 | DCAF7 | P61962 | 91 |
| SMIM10L1 | UTP20 | O75691 | 0 |
| SMIM10L1 | TOMM6 | Q96B49 | 0 |
| SMIM10L1 | MUC15 | Q8N387 | 0 |
| SMIM10L1 | AOAH | P28039 | 0 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0D1DMK2, A0A1B0GUV1, A8MUN3, A9G6D9, B8DP12, L7N648, O90299, P03294, P06791, P0C5K6, P0C854, P0DMW3, P15099, P16791, P16835, P25620, P34245, P40057, P53211, P69616, P69617, P75410, Q04612, Q07649, Q08419, Q32L37, Q3BSH4, Q494R0, Q53513, Q5YCU7, Q5YCU8, Q64747, Q64902, Q6J1A5, Q6J8G1, Q6Q572, Q6REU5, Q6UXP9, Q6ZS49, Q6ZUT4
Diamond homologs: A0A0C4DGP1, P0DMW3, P0DMW4, P0DMW5, Q5U425, Q96HG1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
151 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:11171265:ACCGT:A | donor_gain | 0.9800 |
| 12:11171266:CCGTC:C | donor_gain | 0.9800 |
| 12:11171547:TGCAG:T | donor_loss | 0.9700 |
| 12:11171549:CAGGT:C | donor_loss | 0.9700 |
| 12:11171550:AG:A | donor_loss | 0.9700 |
| 12:11171551:GG:G | donor_loss | 0.9700 |
| 12:11171552:G:GC | donor_loss | 0.9700 |
| 12:11171553:T:G | donor_loss | 0.9700 |
| 12:11171261:GCTT:G | donor_loss | 0.9400 |
| 12:11171262:CTTA:C | donor_loss | 0.9400 |
| 12:11171263:TTA:T | donor_loss | 0.9400 |
| 12:11171264:TACC:T | donor_loss | 0.9400 |
| 12:11171265:ACC:A | donor_loss | 0.9400 |
| 12:11171266:C:CG | donor_loss | 0.9400 |
| 12:11171269:T:TA | donor_gain | 0.9100 |
| 12:11171265:A:AC | donor_gain | 0.9000 |
| 12:11171266:C:CC | donor_gain | 0.9000 |
| 12:11171266:CCGT:C | donor_gain | 0.8900 |
| 12:11171531:A:AG | donor_gain | 0.8200 |
| 12:11175885:TAAG:T | acceptor_gain | 0.8200 |
| 12:11171259:TTGC:T | donor_loss | 0.7900 |
| 12:11171260:TGCT:T | donor_loss | 0.7900 |
| 12:11171465:G:A | donor_gain | 0.7800 |
| 12:11172242:A:AG | donor_gain | 0.7800 |
| 12:11172243:G:GG | donor_gain | 0.7800 |
| 12:11172247:A:G | donor_gain | 0.7800 |
| 12:11175886:AAGG:A | acceptor_gain | 0.7600 |
| 12:11171258:TTTGC:T | donor_loss | 0.7500 |
| 12:11171413:GACAC:G | donor_loss | 0.7300 |
| 12:11171414:ACAC:A | donor_loss | 0.7300 |
AlphaMissense
424 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:11171435:T:C | F27L | 0.985 |
| 12:11171437:C:A | F27L | 0.985 |
| 12:11171437:C:G | F27L | 0.985 |
| 12:11171522:G:C | G56R | 0.985 |
| 12:11171471:T:C | F39L | 0.984 |
| 12:11171473:C:A | F39L | 0.984 |
| 12:11171473:C:G | F39L | 0.984 |
| 12:11171523:G:A | G56D | 0.983 |
| 12:11171547:T:C | L64S | 0.980 |
| 12:11171481:C:A | A42D | 0.977 |
| 12:11171501:T:C | F49L | 0.977 |
| 12:11171503:C:A | F49L | 0.977 |
| 12:11171503:C:G | F49L | 0.977 |
| 12:11171448:T:A | L31H | 0.975 |
| 12:11171471:T:A | F39I | 0.975 |
| 12:11171502:T:C | F49S | 0.975 |
| 12:11171520:C:A | A55E | 0.974 |
| 12:11171502:T:G | F49C | 0.973 |
| 12:11171517:T:A | V54D | 0.972 |
| 12:11171451:C:T | S32F | 0.971 |
| 12:11171525:T:C | S57P | 0.969 |
| 12:11171529:T:A | V58E | 0.965 |
| 12:11171460:T:C | L35P | 0.962 |
| 12:11171485:G:C | W43C | 0.962 |
| 12:11171485:G:T | W43C | 0.962 |
| 12:11171490:T:C | L45P | 0.961 |
| 12:11171513:T:G | Y53D | 0.961 |
| 12:11171478:T:C | L41P | 0.959 |
| 12:11171436:T:C | F27S | 0.958 |
| 12:11171451:C:A | S32Y | 0.958 |
dbSNP variants (sampled 300 via entrez): RS1000099420 (12:11173496 G>T), RS1000422884 (12:11170853 A>G), RS1000874378 (12:11169820 G>A), RS1001132920 (12:11174181 GACAAA>G), RS1001867940 (12:11175294 A>G), RS1002079424 (12:11170156 G>A,T), RS1002088914 (12:11173330 C>CA), RS1002299298 (12:11175509 G>A,C), RS1002538872 (12:11172507 A>G,T), RS1002981587 (12:11172801 C>T), RS1003220351 (12:11171010 T>C), RS1003947269 (12:11173896 C>T), RS1004244144 (12:11171516 G>A,C), RS1004306341 (12:11176465 G>A), RS1004617297 (12:11171289 G>A,C,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| methylmercuric chloride | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects methylation | 1 |
| sodium arsenite | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Gold Compounds | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.